Phase 1A clinical trial of the first-in-class fascin inhibitor NP-G2-044 evaluating safety and anti-tumor activity in patients with advanced and metastatic solid tumors Meeting Abstract
| Authors: | Chung, V.; Jhaveri, K. L.; Von Hoff, D. D.; Huang, X. Y.; Garmey, E. G.; Zhang, J.; Tsai, F. Y. C. |
| Abstract Title: | Phase 1A clinical trial of the first-in-class fascin inhibitor NP-G2-044 evaluating safety and anti-tumor activity in patients with advanced and metastatic solid tumors |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120601070 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.2548 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2548 -- Source: Wos |
